Bacillus subtilis DE111 intake may improve blood lipids and endothelial function in healthy adults
Cardiovascular disease (CVD) is the leading cause of death in the US and worldwide. By 2030 it is anticipated that CVD will claim the lives of more than 24 million people. Throughout the last decade, researchers have investigated the role of the gut microbiota in the development of CVD. Evidence exi...
Saved in:
Published in | Beneficial microbes Vol. 11; no. 7; pp. 621 - 630 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Wageningen Academic Publishers
15.11.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Cardiovascular disease (CVD) is the leading cause of death in the US and worldwide. By 2030 it is anticipated that CVD will claim the lives of more than 24 million people. Throughout the last decade, researchers have investigated the role of the gut microbiota in the development of CVD. Evidence exists for a positive correlation between Bifidobacterium and vascular function, glucose tolerance, and reduced systemic inflammation. Another probiotic species, Bacillus subtilis, has also been found to reduce cholesterol levels in human and animal models. In light of these data, we examined various measures of cardiovascular health after consumption of Bifidobacterium animalis subsp. lactis strain BL04, with and without a cocktail of Escherichia coli-targeting bacteriophages (marketed as PreforPro), Bacillus subtilis strain DE111 or a maltodextrin-based placebo in a healthy human population. In a randomised, double-blind, placebo-controlled 4-week intervention conducted in individuals 18 to 65 years of age with a body mass index of 20 to 34.9, we saw no significant changes in measured CVD parameters among individuals consuming B. lactis with or without bacteriophages. However, B. subtilis supplementation resulted in a significant reduction in total cholesterol relative to baseline measures (-8 mg/dl; P=0.04, confidence interval (CI): -13.40, -0.19), as well as non-high-density lipoprotein-cholesterol (-11 mg/dl; P=0.01, CI: -12.43, -2.07). In addition we observed trending improvements in endothelial function (P=0.05, CI: -0.003, 0.370) and in low-density lipoprotein-cholesterol (P=0.06, CI:-12.29, 0.2864). Strikingly, these effects were seen in a largely healthy population. These data suggest that B. subtilis supplementation may be beneficial for improving risk factors associated with CVD. Further studies in populations of older adults or those with dyslipidaemia and endothelial dysfunction is warranted. |
---|---|
AbstractList | Cardiovascular disease (CVD) is the leading cause of death in the US and worldwide. By 2030 it is anticipated that CVD will claim the lives of more than 24 million people. Throughout the last decade, researchers have investigated the role of the gut microbiota in the development of CVD. Evidence exists for a positive correlation between
and vascular function, glucose tolerance, and reduced systemic inflammation. Another probiotic species,
, has also been found to reduce cholesterol levels in human and animal models. In light of these data, we examined various measures of cardiovascular health after consumption of
subsp.
strain BL04, with and without a cocktail of
-targeting bacteriophages (marketed as PreforPro),
strain DE111 or a maltodextrin-based placebo in a healthy human population. In a randomised, double-blind, placebo-controlled 4-week intervention conducted in individuals 18 to 65 years of age with a body mass index of 20 to 34.9, we saw no significant changes in measured CVD parameters among individuals consuming
with or without bacteriophages. However,
supplementation resulted in a significant reduction in total cholesterol relative to baseline measures (-8 mg/dl;
=0.04, confidence interval (CI): -13.40, -0.19), as well as non-high-density lipoprotein-cholesterol (-11 mg/dl;
=0.01, CI: -12.43, -2.07). In addition we observed trending improvements in endothelial function (
=0.05, CI: -0.003, 0.370) and in low-density lipoprotein-cholesterol (
=0.06, CI:-12.29, 0.2864). Strikingly, these effects were seen in a largely healthy population. These data suggest that
supplementation may be beneficial for improving risk factors associated with CVD. Further studies in populations of older adults or those with dyslipidaemia and endothelial dysfunction is warranted. Cardiovascular disease (CVD) is the leading cause of death in the US and worldwide. By 2030 it is anticipated that CVD will claim the lives of more than 24 million people. Throughout the last decade, researchers have investigated the role of the gut microbiota in the development of CVD. Evidence exists for a positive correlation between Bifidobacterium and vascular function, glucose tolerance, and reduced systemic inflammation. Another probiotic species, Bacillus subtilis, has also been found to reduce cholesterol levels in human and animal models. In light of these data, we examined various measures of cardiovascular health after consumption of Bifidobacterium animalis subsp. lactis strain BL04, with and without a cocktail of Escherichia coli-targeting bacteriophages (marketed as PreforPro), Bacillus subtilis strain DE111 or a maltodextrin-based placebo in a healthy human population. In a randomised, double-blind, placebo-controlled 4-week intervention conducted in individuals 18 to 65 years of age with a body mass index of 20 to 34.9, we saw no significant changes in measured CVD parameters among individuals consuming B. lactis with or without bacteriophages. However, B. subtilis supplementation resulted in a significant reduction in total cholesterol relative to baseline measures (-8 mg/dl; P=0.04, confidence interval (CI): -13.40, -0.19), as well as non-high-density lipoprotein-cholesterol (-11 mg/dl; P=0.01, CI: -12.43, -2.07). In addition we observed trending improvements in endothelial function (P=0.05, CI: -0.003, 0.370) and in low-density lipoprotein-cholesterol (P=0.06, CI:-12.29, 0.2864). Strikingly, these effects were seen in a largely healthy population. These data suggest that B. subtilis supplementation may be beneficial for improving risk factors associated with CVD. Further studies in populations of older adults or those with dyslipidaemia and endothelial dysfunction is warranted. |
Author | Freedman, K.E Grabos, L.E Grubb, D.S Johnson, S.A Trotter, R.E Vazquez, A.R Jones, S Melby, C.L Weir, T.L Gentile, C.L |
Author_xml | – sequence: 1 givenname: R.E surname: Trotter fullname: Trotter, R.E organization: Department of Food Science and Human Nutrition, Colorado State University, 502 W Lake St, Fort Collins, CO 80523-1571, USA – sequence: 2 givenname: A.R surname: Vazquez fullname: Vazquez, A.R organization: Department of Food Science and Human Nutrition, Colorado State University, 502 W Lake St, Fort Collins, CO 80523-1571, USA – sequence: 3 givenname: D.S surname: Grubb fullname: Grubb, D.S organization: Department of Food Science and Human Nutrition, Colorado State University, 502 W Lake St, Fort Collins, CO 80523-1571, USA – sequence: 4 givenname: K.E surname: Freedman fullname: Freedman, K.E organization: Department of Food Science and Human Nutrition, Colorado State University, 502 W Lake St, Fort Collins, CO 80523-1571, USA – sequence: 5 givenname: L.E surname: Grabos fullname: Grabos, L.E organization: Department of Food Science and Human Nutrition, Colorado State University, 502 W Lake St, Fort Collins, CO 80523-1571, USA – sequence: 6 givenname: S surname: Jones fullname: Jones, S organization: Department of Food Science and Human Nutrition, Colorado State University, 502 W Lake St, Fort Collins, CO 80523-1571, USA – sequence: 7 givenname: C.L surname: Gentile fullname: Gentile, C.L organization: Department of Food Science and Human Nutrition, Colorado State University, 502 W Lake St, Fort Collins, CO 80523-1571, USA – sequence: 8 givenname: C.L surname: Melby fullname: Melby, C.L organization: Department of Food Science and Human Nutrition, Colorado State University, 502 W Lake St, Fort Collins, CO 80523-1571, USA – sequence: 9 givenname: S.A surname: Johnson fullname: Johnson, S.A organization: Department of Food Science and Human Nutrition, Colorado State University, 502 W Lake St, Fort Collins, CO 80523-1571, USA – sequence: 10 givenname: T.L surname: Weir fullname: Weir, T.L email: tiffany.weir@colostate.edu organization: Department of Food Science and Human Nutrition, Colorado State University, 502 W Lake St, Fort Collins, CO 80523-1571, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33161737$$D View this record in MEDLINE/PubMed |
BookMark | eNo9kMtOwzAQRS1URB-wYo_8Ayl23Mb2kpbykIrYwDoaP0JdHCeKHVD_nlQFFjN3FndGd84UjUITLELXlMyZzMnt6iUnOZkTwuQZmlDBiywXko7-Z8HGaBrjnpBC5FJcoDFjtKCc8QlSK9DO-z7i2KvkvIv4fkMpxS4k-LS4hgN2dds1XxYr3zQGe9c6EzEEg20wTdpZ78Djqg86uSYMi3hnwafdAYPpfYqX6LwCH-3Vr87Q-8Pmbf2UbV8fn9d320wtJEmZEQUXvOK8ImooQxlVVFVyUKOUkFovFRTCCEGk4QQIAb7keQ5ca7YQSzZDN6e7ba9qa8q2czV0h_Lv2cFQnAzf8GGDC0MDDcbWTpf7pu_CkK6kpDxSLU9UyyNV9gMrm2nK |
CitedBy_id | crossref_primary_10_1093_femsle_fnad016 crossref_primary_10_1039_D3FO00157A crossref_primary_10_3390_ijms22052453 crossref_primary_10_3390_ani12070870 crossref_primary_10_3390_applmicrobiol3030064 crossref_primary_10_3390_microorganisms10051038 crossref_primary_10_1080_19490976_2022_2122668 crossref_primary_10_3390_fermentation10020078 crossref_primary_10_3920_BM2022_0081 crossref_primary_10_3389_fmicb_2022_1101144 crossref_primary_10_1016_j_ahjo_2022_100219 crossref_primary_10_36105_psrua_2023v3n6_02 crossref_primary_10_1007_s10068_024_01608_x crossref_primary_10_1152_ajpheart_00764_2023 crossref_primary_10_3390_app122412607 crossref_primary_10_1124_molpharm_121_000338 crossref_primary_10_1111_1462_2920_15934 crossref_primary_10_1016_j_cbpc_2023_109712 crossref_primary_10_3920_BM2022_0117 |
ContentType | Journal Article |
Copyright | 2020 Wageningen Academic Publishers |
Copyright_xml | – notice: 2020 Wageningen Academic Publishers |
DBID | J7E CGR CUY CVF ECM EIF NPM |
DOI | 10.3920/BM2020.0039 |
DatabaseName | Wageningen Academic Publishers Open Access Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: J7E name: Wageningen Academic Publishers Open Access url: http://www.wageningenacademic.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 1876-2891 |
EndPage | 630 |
ExternalDocumentID | 33161737 10_3920_BM2020_0039 |
Genre | Randomized Controlled Trial Journal Article |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R01 HL144611 |
GroupedDBID | - 0R 53G ACPRK AENEX AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS EBS EJD HZ J7E MEN MET O9- PQEST PQQKQ RIG --- 0R~ AAHBH ABJNI ADZLE AHYGR ALJKW CGR CUY CVF ECM EIF H13 HZ~ IPNFZ NPM |
ID | FETCH-LOGICAL-b490t-d86787f77f0b7f0d131b1bf9131dbb89cc5ba68d8809d70a00a75722a7cc34853 |
IEDL.DBID | J7E |
ISSN | 1876-2883 |
IngestDate | Sat Sep 28 08:22:57 EDT 2024 Mon Jan 18 12:30:17 EST 2021 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 7 |
Keywords | cardiovascular disease vascular function probiotic bacteriophage Bifidobacterium lactis Bacillus subtilis |
Language | English |
License | http://creativecommons.org/licenses/by-nc-sa/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-b490t-d86787f77f0b7f0d131b1bf9131dbb89cc5ba68d8809d70a00a75722a7cc34853 |
OpenAccessLink | http://dx.doi.org/10.3920/BM2020.0039 |
PMID | 33161737 |
PageCount | 10 |
ParticipantIDs | pubmed_primary_33161737 wageningenacademic_journals_10_3920_BM2020_0039 |
ProviderPackageCode | J7E MEN |
PublicationCentury | 2000 |
PublicationDate | 20201115 |
PublicationDateYYYYMMDD | 2020-11-15 |
PublicationDate_xml | – month: 11 year: 2020 text: 20201115 day: 15 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Beneficial microbes |
PublicationTitleAlternate | Benef Microbes |
PublicationYear | 2020 |
Publisher | Wageningen Academic Publishers |
Publisher_xml | – name: Wageningen Academic Publishers |
References | Szulińska, M., Łoniewski, I., Skrypnik, K., Sobieska, M., Korybalska, K., Suliburska, J. and Bogdański, P., 2018. Multispecies probiotic supplementation favorably affects vascular function and reduces arterial stiffness in obese postmenopausal women – a 12-week placebo-controlled and randomized clinical study. Nutrients 10: 1672. https://doi.org/10.3390/nu10111672 Rice, B.H., 2014. Dairy and cardiovascular disease: a review of recent observational research. Current Nutrition Reports 3: 130-138. https://doi.org/10.1007/s13668-014-0076-4 Kelly, R.P., Millasseau, S.C., Ritter, J.M. and Chowienczyk, P.J., 2001. Vasoactive drugs influence aortic augmentation index independently of pulse-wave velocity in healthy men. Hypertension 37: 1429-1433. https://doi.org/10.1161/01.HYP.37.6.1429 Malik, M., Suboc, T.M., Tyagi, S., Salzman, N., Wang, J., Ying, R., Tanner, M.J., Kakarla, M., Baker, J.E. and Widlansky, M.E., 2018. Lactobacillus plantarum 299v supplementation improves vascular endothelial function and reduces inflammatory biomarkers in men with stable cronary artery disease. Circulation Research 123: 1091-1102. https://doi.org/10.1161/CIRCRESAHA.118.313565 Sawilowsky, S.S., 2009. New effect size rules of thumb. Journal of Modern Applied Statistical Methods 8: 597-599. https://doi.org/10.22237/jmasm/1257035100 Cani, P.D., Bibiloni, R., Knauf, C., Waget, A., Neyrinck, A.M., Delzenne, N.M. and Burcelin, R., 2008. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481. https://doi.org/10.2337/db07-1403 Seo, K.-C., Kim, M.-J., Hong, S.-H., Cha, S.-Y., Noh, J.-S., Kim, M.-J. and Song, Y.-O., 2010. The hypocholesterolemic effects of soymilk fermented with Bacillus subtilis compared to soymilk with Cheonggukjang powder in apolipoprotein e knockout mice. Preventive Nutrition and Food Science 15: 83-87. https://doi.org/10.3746/jfn.2010.15.2.083 Koren, O., Spor, A., Felin, J., Fak, F., Stombaugh, J., Tremaroli, V., Behre, C.J., Knight, R., Fagerberg, B., Ley, R.E. and Backhed, F., 2011. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proceedings of the National Academy of Sciences of the USA 108, Suppl. 1: 4592-4598. https://doi.org/10.1073/pnas.1011383107 Hanifi, A., Culpepper, T., Mai, V., Anand, A., Ford, A.L., Ukhanova, M., Christman, M., Tompkins, T.A. and Dahl, W.J., 2015. Evaluation of Bacillus subtilis R0179 on gastrointestinal viability and general wellness: a randomised, double-blind, placebo-controlled trial in healthy adults. Beneficial Microbes 6: 19-27. https://doi.org/10.3920/BM2014.0031 Xie, N., Cui, Y., Yin, Y.-N., Zhao, X., Yang, J.-W., Wang, Z.-G., Fu, N., Tang, Y., Wang, X.-H., Liu, X.-W., Wang, C.-L. and Lu, F.-G. 2011. Effects of two Lactobacillus strains on lipid metabolism and intestinal microflora in rats fed a high-cholesterol diet. BMC Complementary and Alternative Medicine 11: 53. https://doi.org/10.1186/1472-6882-11-53 Febvre, H., Rao, S., Gindin, M., Goodwin, N., Finer, E., Vivanco, J., Lu, S., Manter, D., Wallace, T. and Weir, T., 2019. PHAGE study: effects of supplemental bacteriophage intake on inflammation and gut microbiota in healthy adults. Nutrients 11: 666. https://doi.org/10.3390/nu11030666 Zouari, R., Ben Abdallah-Kolsi, R., Hamden, K., Feki, A.E., Chaabouni, K., Makni-Ayadi, F., Sallemi, F., Ellouze-Chaabouni, S. and Ghribi-Aydi, D., 2015. Assessment of the antidiabetic and antilipidemic properties of Bacillus subtilis spb1 biosurfactant in alloxan-induced diabetic rats: antidiabetic and antilipidemic properties of Bacillus subtilis SPB1 biosurfactant. Biopolymers 104: 764-774. https://doi.org/10.1002/bip.22705 Battson, M.L., Lee, D.M., Jarrell, D.K., Hou, S., Ecton, K.E., Weir, T.L. and Gentile, C.L., 2018a. Suppression of gut dysbiosis reverses Western diet-induced vascular dysfunction. American Journal of Physiology – Endocrinology and Metabolism 314: E468-E477. https://doi.org/10.1152/ajpendo.00187.2017 Battson, M.L., Lee, D.M., Weir, T.L. and Gentile, C.L., 2018b. The gut microbiota as a novel regulator of cardiovascular function and disease. Journal of Nutritional Biochemistry 56: 1-15. https://doi.org/10.1016/j.jnutbio.2017.12.010 Gibson, G.R., Hutkins, R., Sanders, M.E., Prescott, S.L., Reimer, R.A., Salminen, S.J., Scott, K., Stanton, C., Swanson, K.S., Cani, P.D., Verbeke, K. and Reid, G., 2017. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nature Reviews Gastroenterology and Hepatology 14: 491-502. https://doi.org/10.1038/nrgastro.2017.75 Cohen, J., 2013. Statistical power analysis for the behavioral sciences. Taylor and Francis, London, UK. Matsumoto, M., Kitada, Y. and Naito, Y., 2019. Endothelial function is improved by inducing microbial polyamine production in the gut: a randomized placebo-controlled trial. Nutrients 11: 1188. https://doi.org/10.3390/nu11051188 Yelland, L.N., Sullivan, T.R., Voysey, M., Lee, K.J., Cook, J.A. and Forbes, A.B., 2015. Applying the intention-to-treat principle in practice: guidance on handling randomisation errors. Clinical Trials 12: 418-423. https://doi.org/10.1177/1740774515588097 Litwin, N.S., Van Ark, H.J., Hartley, S.C., Michell, K.A., Vazquez, A.R., Fischer, E.K., Melby, C.L., Weir, T.L., Wei, Y., Rao, S., Hildreth, K.L., Seals, D.R., Pagliassotti, M.J. and Johnson, S.A., 2019. Impact of red beetroot juice on vascular endothelial function and cardiometabolic responses to a high-fat meal in middle-aged/older adults with overweight and obesity: a randomized, double-blind, placebo-controlled, crossover trial. Current Developments in Nutrition 3: 113. https://doi.org/10.1093/cdn/nzz113 Ghoneim, M.A.M., Hassan, A.I., Mahmoud, M.G. and Asker, M.S., 2016. Effect of polysaccharide from Bacillus subtilis sp. on cardiovascular diseases and atherogenic indices in diabetic rats. BMC Complementary and Alternative Medicine 16: 112. https://doi.org/10.1186/s12906-016-1093-1 Karlsson, F.H., Fåk, F., Nookaew, I., Tremaroli, V., Fagerberg, B., Petranovic, D., Bäckhed, F. and Nielsen, J., 2012. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nature Communications 3: 1245. https://doi.org/10.1038/ncomms2266 Bernini, L.J., Simão, A.N.C., Alfieri, D.F., Lozovoy, M.A.B., Mari, N.L., De Souza, C.H.B., Dichi, I. and Costa, G.N., 2016. Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: a randomized trial. Effects of probiotics on metabolic syndrome. Nutrition 32: 716-719. https://doi.org/10.1016/j.nut.2015.11.001 Johnson, S.A., Litwin, N.S. and Seals, D.R., 2019. Age-related vascular dysfunction: what registered dietitian nutritionists need to know. Practice Applications Professional Practice| 119: 1790-1796. https://doi.org/10.1016/j.jand.2019.03.016 Ziganshina, E.E., Sharifullina, D.M., Lozhkin, A.P., Khayrullin, R.N., Ignatyev, I.M. and Ziganshin, A.M. 2016. Bacterial communities associated with atherosclerotic plaques from Russian individuals with atherosclerosis. PLoS ONE 11: e0164836. https://doi.org/10.1371/journal.pone.0164836 Hitosugi, M., Hamada, K. and Misaka, K. 2015. Effects of Bacillus subtilis var. Natto products on symptoms caused by blood flow disturbance in female patients with lifestyle diseases. International Journal of General Medicine 2015: 41-46. https://doi.org/10.2147/IJGM.S76588 Mozaffarian, D. and Wu, J.H.Y., 2018. Flavonoids, dairy foods, and cardiovascular and metabolic health: a review of emerging biologic pathways. Circulation Research 122: 369-384. https://doi.org/10.1161/circresaha.117.309008 Khalesi, S., Sun, J., Buys, N. and Jayasinghe, R., 2014. Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension 64: 897-903. https://doi.org/10.1161/hypertensionaha.114.03469 Fechner, A., Kiehntopf, M. and Jahreis, G., 2014. The formation of short-chain fatty acids is positively associated with the blood lipid-lowering effect of lupin kernel fiber in moderately hypercholesterolemic adults. Journal of Nutrition 144: 599-607. https://doi.org/10.3945/jn.113.186858 Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., Morelli, L., Canani, R.B., Flint, H.J., Salminen, S., Calder, P.C. and Sanders, M.E. 2014. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology and Hepatology 11: 506-514. https://doi.org/10.1038/nrgastro.2014.66 Kumar, M., Nagpal, R., Kumar, R., Hemalatha, R., Verma, V., Kumar, A., Chakraborty, C., Singh, B., Marotta, F., Jain, S. and Yadav, H. 2012. Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseases. Experimental Diabetes Research 2012: 902917. https://doi.org/10.1155/2012/902917 Schauf, S., Nakamura, N. and Castrillo, C., 2019. Effect of Calsporin® (Bacillus subtilis C-3102) addition to the diet on faecal quality and nutrient digestibility in healthy adult dogs. Journal of Applied Animal Nutrition 7: e3. https://doi.org/10.1017/jan.2019.2 |
References_xml | – article-title: Statistical power analysis for the behavioral sciences |
SSID | ssj0068298 |
Score | 2.3456943 |
Snippet | Cardiovascular disease (CVD) is the leading cause of death in the US and worldwide. By 2030 it is anticipated that CVD will claim the lives of more than 24... |
SourceID | pubmed wageningenacademic |
SourceType | Index Database Publisher |
StartPage | 621 |
SubjectTerms | Adolescent Adult Aged Bacillus subtilis - physiology Cholesterol - blood Cholesterol, LDL - blood Double-Blind Method Female Hemodynamics - drug effects Humans Lipids - blood Male Middle Aged Probiotics - administration & dosage Probiotics - pharmacology RESEARCH ARTICLE Young Adult |
Title | Bacillus subtilis DE111 intake may improve blood lipids and endothelial function in healthy adults |
URI | http://dx.doi.org/10.3920/BM2020.0039 https://www.ncbi.nlm.nih.gov/pubmed/33161737 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV07T8MwELagLCyIild5yQNrVNtJamekUFQhtWKgUrfI9jlSRAgVSYX67zknQRSYGOJkyC3nO38--7s7Qm6y2EjNHQ80JBBEkXCB1trTpoSwljmrbEOQnY-mi-hxGS-_STQ_b_ARu9lwPMP43POvwmSX7Am_QfFmKydfC-5IiablLUfHDnzz3DYN77fwFsT0P9BXyyZ5SXcs9C1QeTgkB91ukN6209cnO648ImasbV4U64pWa1PnRV7R-wkuFjQva_3i6Kve0Lw5C3C04Z3TIl_lUFFdAnUl-JyqAs2KeszyekdB2uY7bmhTb6M6JouHyfPdNOhaIQQmSlgdgEJQkZmUGTP4AA-54SZL8A3GqMTa2OiRAvTGBCTTjGkZSyG0tDaMEJJPSK98K90ZoZIbyZTB3yCOHAbAIDMDHEDqWFkRDchpq6d01da7SMPQB0GhHJDhX8Wlnc1XKYYTXudpq3NfdDQ5_7fEBdn33z7bj8eXpFe_r90Vwn5trptJx3H-NPsE7F2qHg |
link.rule.ids | 315,786,790,26153,27955,27956 |
linkProvider | Wageningen Academic Publishers |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Bacillus+subtilis+DE111+intake+may+improve+blood+lipids+and+endothelial+function+in+healthy+adults&rft.jtitle=Beneficial+microbes&rft.au=Trotter%2C+R.E&rft.au=Vazquez%2C+A.R&rft.au=Grubb%2C+D.S&rft.au=Freedman%2C+K.E&rft.date=2020-11-15&rft.pub=Wageningen+Academic+Publishers&rft.issn=1876-2883&rft.eissn=1876-2891&rft.volume=11&rft.issue=7&rft.spage=621&rft.epage=630&rft_id=info:doi/10.3920%2FBM2020.0039&rft.externalDocID=10_3920_BM2020_0039 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1876-2883&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1876-2883&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1876-2883&client=summon |